The ratings of 11 Health Care Equipment & Supplies stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
This is a rough week for Varian Medical Systems, Inc. (VAR). The company’s rating falls to D from the previous week’s C. Varian Medical Systems, Inc. manufactures and sells equipment and software products for treating cancer with radiotherapy and radiosurgery. For more information, get Portfolio Grader’s complete analysis of VAR stock.
This week, LDR Holding Corporation (LDRH) drops from a C to a D rating. The company also gets F’s in earnings momentum. For more information, get Portfolio Grader’s complete analysis of LDRH stock.
This week, AngioDynamics, Inc.’s (ANGO) rating worsens to a F from the company’s D rating a week ago. AngioDynamics, Inc. is a developer and manufacturer of gastrointestinal contrast agents and related imaging accessories. The company also gets F’s in operating margin growth and earnings growth. For more information, get Portfolio Grader’s complete analysis of ANGO stock.
Syneron Medical Ltd (ELOS) earns a F this week, moving down from last week’s grade of D. Syneron Medical Ltd designs, develops, and markets aesthetic medical products based on proprietary Electro-Optical Synergy technologies. The company also gets F’s in operating margin growth, earnings revisions, and earnings surprise. For more information, get Portfolio Grader’s complete analysis of ELOS stock.
Sientra, Inc. (SIEN) slips from a D to a F this week. The company also gets F’s in earnings momentum, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of SIEN stock.
Xtant Medical Holdings, Inc. (XTNT) declines this week from a C to a D. The company also gets F’s in earnings revisions, earnings surprise, earnings momentum, and free cash flow. For more information, get Portfolio Grader’s complete analysis of XTNT stock.
CryoPort, Inc. (CYRX) is having a tough week. The company’s rating falls from a C to a D. The company also gets F’s in earnings momentum, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of CYRX stock.
Slipping from a D to a F rating, Sunshine Heart, Inc. (SSH) takes a hit this week. Sunshine Heart, Inc. an early-stage medical device company, focuses on developing, manufacturing, and commercializing C-Pulse Heart Assist System for treatment of Class III and ambulatory Class IV heart failure. The company also gets F’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of SSH stock.
Akers Biosciences, Inc. (AKER) experiences a ratings drop this week, going from last week’s C to a D. The company also gets F’s in sales growth, earnings revisions, earnings momentum, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of AKER stock.
TearLab Corp.’s (TEAR) rating weakens this week, dropping to a D versus last week’s C. TearLab Corp. is an in-vitro diagnostics company. The company also gets F’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of TEAR stock.
Roka Bioscience Inc (ROKA) gets weaker ratings this week as last week’s D drops to a F. The company also gets F’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of ROKA stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
